About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Pharma Foods International Co., Ltd.(2929) Summary

2929
TSE Prime
Pharma Foods International Co., Ltd.
747
JPY
-44
(-5.56%)
Apr 9, 3:30 pm JST
5.13
USD
Apr 9, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
13.5
PBR
1.80
Yield
3.35%
Margin Trading Ratio
2.27
Stock Price
Apr 9, 2025
Opening Apr 9, 9:03 am
770 JPY 5.28 USD
Previous Close Apr 8
791 JPY 5.36 USD
High Apr 9, 9:14 am
772 JPY 5.29 USD
Low Apr 9, 1:29 pm
746 JPY 5.13 USD
Volume
106,800
Trading Value
0.08B JPY 0.56M USD
VWAP
756.32 JPY 5.2 USD
Minimum Trading Value
74,700 JPY 513 USD
Market Cap
0.02T JPY 0.15B USD
Number of Trades
394
Liquidity & Number of Trades
As of Apr 9, 2025
Liquidity
Slightly High
1-Year Average
641
1-Year High Jul 26, 2024
6,009
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 62,600 726,800 11.61
Mar 28, 2025 101,300 690,700 6.82
Mar 21, 2025 109,500 684,500 6.25
Mar 14, 2025 103,100 708,600 6.87
Mar 7, 2025 78,300 758,500 9.69
Company Profile
Pharma Foods International Co., Ltd. primarily sells functional food ingredients such as GABA and folic acid egg supplements. The company is also involved in the development of antibody-based pharmaceuticals.
Sector
Foods
Pharma Foods International Co., Ltd. engages in the research, development, and manufacturing of functional ingredients, health foods, and pharmaceuticals. The company operates a B2B business, supplying materials to food and pharmaceutical manufacturers as well as distributors. They offer ingredients such as Pharma GABA, which provides stress relief and blood pressure improvement functions. Additionally, the company develops and sells its own brand products both domestically and internationally. In their B2C business, Pharma Foods International directly sells supplements, quasi-drugs, and cosmetics containing their proprietary functional ingredients to consumers through mail order. The Biomedical division conducts drug discovery research and development targeting intractable diseases such as autoimmune disorders and fibrosis, while also providing contracted services like proteome analysis. Furthermore, the company has expanded into venture capital and investment businesses.